How can germline mutations distinguish risk for lethal and indolent prostate cancer?
The BILCAP study: a better overal survivial of biliary tract cancers with adjuvant capecitabine
Interesting topics presented at ESMO 2017
The importance of physical exercise to contribute to a lower risk of relapse in breast cancer
Landmark clinical trials for melanoma treatment